Julie McKinney, PhD: “If you’re going to disinfect, you’re going to let it sit for three minutes and then you’re going to wipe it. If you’re going to sanitize, you only have to leave it for 30 seconds and then wipe.”
A study in the American Journal of Infection Control got a lot of attention a couple of weeks ago when it said that certain Lysol products are effective against coronavirus disease 2019 (COVID-19) and the Environmental Protection Agency quickly agreed. Julie McKinney, PhD, global director of microbiology and virology at Reckitt Benckiser, the company that makes the products, recently sat down with Infection Control Today® to talk about what precipitated the study and what might be the broader ramifications of the findings. Those ramifications expand beyond the healthcare environment. “Everybody is going to have to increase their level of cleaning and disinfection and sanitation, if they’re going to have consumers come into their spaces…,” says McKinney. “We’ve gotten a lot of requests from industry to be able to help them understand how to best use the products in their environment.”
IP LifeLine: Keeping it Together When Things Fall Apart: Maintaining Balance When Life Gets Messy
July 25th 2024Balancing personal struggles and professional responsibilities during crises requires self-awareness, self-compassion, healthy boundaries, and support networks. Embrace these strategies to navigate and overcome challenges.
CDC Speaks About New Data From Antimicrobial Resistance Threats Fact Sheet
July 18th 2024In a follow-up to Infection Control Today's (ICT's) article on the CDC's Antimicrobial Resistance Threats in the US 2021-2022 release, Michael Craig, MPP, director of CDC's Antimicrobial Resistance Coordination and Strategy Unit, answers ICT's questions.
Evaluating the Impact of Testing and Timely Diagnosis on Disease Transmission
July 16th 2024A new model demonstrates optimal testing strategies for reducing disease transmission, highlighting pathogen-specific recommendations and the importance of human behavior in effective diagnosis and isolation.
IP LifeLine: Keeping it Together When Things Fall Apart: Maintaining Balance When Life Gets Messy
July 25th 2024Balancing personal struggles and professional responsibilities during crises requires self-awareness, self-compassion, healthy boundaries, and support networks. Embrace these strategies to navigate and overcome challenges.
CDC Speaks About New Data From Antimicrobial Resistance Threats Fact Sheet
July 18th 2024In a follow-up to Infection Control Today's (ICT's) article on the CDC's Antimicrobial Resistance Threats in the US 2021-2022 release, Michael Craig, MPP, director of CDC's Antimicrobial Resistance Coordination and Strategy Unit, answers ICT's questions.
Evaluating the Impact of Testing and Timely Diagnosis on Disease Transmission
July 16th 2024A new model demonstrates optimal testing strategies for reducing disease transmission, highlighting pathogen-specific recommendations and the importance of human behavior in effective diagnosis and isolation.
2 Commerce Drive
Cranbury, NJ 08512